Third Rock woos top Roche scientist Sanjay Keswani to the helm of biotech startup Rheos Medicines
Five months after Third Rock partner Abbie Celniker officially launched Rheos Medicines with an aim at becoming a leader in immunometabolism, the startup has wooed a top Roche scientist to the helm.
Sanjay Keswani has been named CEO at the Cambridge, MA-based company, joining a large migration of top executives leaving Big Pharma for the fast-growing start-up crowd.
Recruiting Keswani is a coup for Third Rock.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.